Table 1: Inclusion and exclusion criteria of the study.

Inclusion criteriaExclusion criteria

MaleTreatment with lipid-lowering drugs <1 year prior to the study
Age 25–65 yearsKnown history of diabetes or fasting glucose level >110 mg/dL
NonsmokerAntihypertensive medication
Proteinuria <150 mg/24 hoursLifeexpectancy <1 year
Dipstick negative hematuriaPharmacological treatment with inotropes
Blood pressure <135 mm systolic, <85 mm diastolicAcute or chronic inflammatory process, use of anti-inflammatory drugs, or immunosuppression
Waist circumference <94 cmClinically active malignant disease
Administration of any investigational drug within 30 days preceding the study start and during the study
Known intolerance to rosuvastatin or other statins
Acute or chronic liver disease or ALAT >2.0 × upper limit of normal (ULN) at enrolment visit.
Chronic muscle disease such as dermatomyositis or polymyositis or unexplained creatinine kinase (CK) above 3 × ULN at enrolment
Uncontrolled hypothyroidism as indicated by a thyroid-stimulating hormone (TSH) >2 × ULN at enrolment
Renal insufficiency: creatinine >2.0 mg/dL
Known or suspect alcohol or drug abuse